Journal of Leukemia : Citations & Metrics Report
Articles published in Journal of Leukemia have been cited by esteemed scholars and scientists all around the world. Journal of Leukemia has got h-index 11, which means every article in Journal of Leukemia has got 11 average citations.
Following are the list of articles that have cited the articles published in Journal of Leukemia.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
50 | 56 | 62 | 62 | 23 | 11 | 8 | 22 | 23 | 48 | 50 | 29 |
Research, Review articles and Editorials |
38 | 44 | 28 | 40 | 2 | 7 | 7 | 14 | 10 | 24 | 27 | 18 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
12 | 12 | 34 | 22 | 21 | 4 | 1 | 8 | 13 | 24 | 23 | 11 |
Conference proceedings |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 28 | 0 | 0 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
0 | 0 | 0 | 54 | 59 | 64 | 98 | 0 | 74 | 0 | 0 | 0 |
Journal total citations count | 618 |
Journal impact factor | 2.11 |
Journal 5 years impact factor | 3.71 |
Journal cite score | 3.91 |
Journal h-index | 11 |
Journal h-index since 2019 | 8 |
Important citations (462)
Apoptotic pathways and targeted therapies |
|
Ala n, jcna a, dsb n, tila a, eta k. research & reviews: journal of medical and health sciences. |
|
Lu j, hou j, liu ky, parmar s, de la fuente a, et al.(2016) asia-pacific hematology consortium report on approach to multiple myeloma. survey results from the 6th international hematologic malignancies conference: bridging the gap 2015, beijing, china. leukemia & lymphoma.57:1534-1538. |
|
Cardiotoxic drugs: classification of adverse reactions and mechanisms of action |
|
Early mortality in multiple myeloma: the time-dependent impact of comorbidity: a population-based study in 621 real-life patients |
|
Iss versus r-iss for risk stratification of multiple myeloma patients undergoing autologous stem cell transplant |
|
Ala n, jcna a, dsb n, tila a, eta k. research & reviews: journal of medical and health sciences. |
|
Städler n, shang a, bosch f, briggs a, goede v,et al. (2016) a systematic review and network meta-analysis to evaluate the comparative efficacy of interventions for unfit patients with chronic lymphocytic leukemia. advances in therapy.33:1814-1830. |
|
Ala n, jcna a, dsb n, tila a, eta k. research & reviews: journal of medical and health sciences. |
|
Cornet e, mossafa h, courel k, lesesve jf, troussard x (2016) persistent polyclonal binucleated b-cell lymphocytosis and mecom gene amplification. bmc research notes.9:138. |
|
Hodeib h, shahbah a (2016)dipeptidyl peptidase-4 (cd26): a prognostic marker in patients with b-cell chronic lymphocytic leukemia. the egyptian journal of haematology. 41:206. |
|
The multi-tyrosine kinase inhibitor ponatinib for chronic myeloid leukemia: real-world data |
|
Sharma r, harish r. research & reviews: journal of medical and health sciences. month.4:3. |
|
Plasma soluble cd30 as a possible marker of adult t-cell leukemia in htlv-1 carriers: a nested case-control study |
|
Shedding by adam10 and adam17 is associated with progression of adult t-cell leukemia/lymphoma |
|
Research and reviews: journal of medical and health sciences |
|
Takemoto s, kozako t, pornkuna r. shedding by adam10 and adam17 is associated with progression of adult t-cell leukemia/lymphoma. |
|
Col1a1 polymorphism and neurological complications in pediatric acute lymphoblastic leukemia patients and their associations with altered bone mineral density |
|
Brachial plexus chloroma as a presenting feature of relapse in a child with kmt2a-rearranged acute lymphoblastic leukemia, a case report |
|
Wang xi, lu x, yin cc, zhao l, bueso-ramos ce, et al .(2016) myeloid neoplasms associated with t (3; 12)(q26. 2; p13) are clinically aggressive and frequently harbor flt3 mutations: a report of 8 cases and review of literature. journal of leukemia. |
|